NYSE:MANE 4 February 2026

Veradermics IPO Pops Above Range as Eli Lilly Lines Up a 5% Stake Play

Veradermics priced its upsized IPO at $17 per share, raising about $256.3 million ahead of its NYSE debut under the ticker “MANE” on Feb. 4. Eli Lilly disclosed plans to acquire up to 4.9% of post-IPO shares, though the move is not binding. Veradermics sold 15,077,647 new shares, valuing the company at roughly $596 million.

4 February 2026

Biotechnology·NYSE:MANE·Pharmaceutical Industry·Stock Market

Rolls-Royce Shares Surge £5bn Amid Iran Conflict and Military Orders
April 8, 2026, 6:01 AM EDT. Rolls-Royce shares jumped 6.6%, adding over £5 billion in market value in a single day on April 1. The surge followed U.S. President Trump's optimistic comments on a potential end to the Iran conflict, which has severely impacted civilian flights and thus Rolls-Royce's maintenance revenues. Additionally, Rolls-Royce secured one of its largest military orders ever-power packs for 200 German military vehicles-highlighting increased government defence spending. Broker upgrades and strong full-year results also contributed. While the war has caused a 19% share price drop since its start due to reduced flying hours and inflation, the recent defence contracts may signal sustained long-term growth for the FTSE 100 engineering firm.